Δ9-tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats
- 30 November 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 250 (1) , 205-208
- https://doi.org/10.1016/0014-2999(93)90646-y
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The evidence for the existence of cannabinoid receptorsGeneral Pharmacology: The Vascular System, 1993
- Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate CyclaseJournal of Neurochemistry, 1993
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea‐pig small intestineBritish Journal of Pharmacology, 1992
- Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogsPharmacology Biochemistry and Behavior, 1991
- Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoidsNeuropharmacology, 1991
- Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in miceNeuropharmacology, 1988
- Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxideNeuropharmacology, 1988